Recall: D-0283-2024

Class II - Potentially Harmful

Class IIClassification

2024-01-05Initiated

TerminatedStatus

Lupin Pharmaceuticals Inc.Firm

Product

Rifampin Capsules USP 150mg, 30-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States, Manufactured Lupin Limited, Aurangabad 431 210 INDIA, NDC 68180-658-06

Reason

Subpotent Drug and Failed Impurities/Degradation Specifications

Distribution

Product was distributed to 32 Wholesale/distributor accounts who further distributed the product to 156 distribution sites.

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.